ASX 200 limped to a 3-point gain to 7091 (0.04%) ahead of US CPI. Six sessions in a row. Just. CSL was the biggest drag on the index as positive drug trials in US marred outlook for medical companies. The stock fell 6,3%, RMD down 5.3% on same effect.
CBA had its AGM yesterday – the share price dropped 0.31% (hardly changed), with one…
CSL fell 6.3% today continuing its nasty downtrend, as the GLP-1 (obesity drugs) juggernaut continues to smash…
US equities rose for a third consecutive day following more dovish comments from Fed officials…
As the market rallies on this “Dovish Pivot” there are no end of ideas to buy. From big quality stocks with weekly (more significant) buy signals (TLS, TCL, RMD, COL, APA, AWC) to interest rate sensitive sectors (REITs, Utilities, Infrastructure), to Healthcare (CSL, RMD), to “Risk On” stocks in the technology and sentiment driven sectors (Lithium). There are daily buy signals for instance, on WTC, WEB, MIN, IGO, AKE. Take your pick. The big gamble is whether this Dovish Pivot is to be believed or whether it’s a one (or three) day wonder.
SMALL CAP PORTFOLIO SUMMARY Selling into the rally. Some GEAR and some LRS. Lithium stocks…
Taking a few bets on this Dovish Pivot sticking. Even if it doesn’t stick, the downside is limited. A lots of daily buy signals around.
Weekly buy signals as well. Interest rate sensitive sectors on the rise. Risk on sentiment driven sectors bottoming. If you want to buy banks for a run into results, the timing looks as good as it is going to get. Hamas-Israel conflict being overlooked by the market. Oil price down.
ASX 200 rose another 48 points to 7088 (+0.7%) up for a fifth consecutive session, bouncing back…
US equities rose for a third consecutive day following more dovish comments from Fed officials pushing bond yields sharply lower.
The Dovish Pivot has obscured the Hamas-Israeli conflict. The Fed messaging has changed. Is it real, or just a moment?